Engineering of osteochondral tissue with bone marrow mesenchymal progenitor: Cells in a derivatized hyaluronan-gelatin composite sponge

被引:134
作者
Angele, P
Kujat, R
Nerlich, M
Yoo, J
Goldberg, V
Johnstone, B
机构
[1] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA
[2] Univ Regensburg, Dept Trauma Surg, D-8400 Regensburg, Germany
来源
TISSUE ENGINEERING | 1999年 / 5卷 / 06期
关键词
D O I
10.1089/ten.1999.5.545
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The aim of this study was to investigate the-potential Of a composite matrix, containing esterified hyaluronic acid and gelatin, to facilitate the-osteochondral differentiation of culture-expanded, bone marrow-derived mesenchymal progenitor cells. The cell loading characteristics and the effects of the matrix on cell differentiation were examined in vitro and in vivo. Empty and cell-loaded composites were cultivated for up to 28 days in a chemically defined medium with or without transforming growth factor-beta 1 (TGF-beta 1). A type II collagen-rich extracellular matrix was produced by cells-loaded:ih the matrix and cultured in the presence of TGF-beta 1. Empty and cell-loaded matrices were:also implanted subcutaneously in immunodeficient mice. Three types of implant,were: used: empty (group I), cell-loaded matrices (Group II), and cell-loaded matrices cultured for 14 days in vitro in defined medium with TGF-beta 1 (group III). No osteochondral differentiation was found in implanted empty matrices; however, the matrix supported osteochondrogenic cell differentiation in the cell-loaded implants. Preculture in vitro in a chondrogenic medium increased the percentage of osteochondral tissue found in the constructs after 3 weeks. These results indicate the potential use of this composite matrix for delivery of bone marrow-derived mesenchymal progenitor cells for the repair of chondral and osseous defects. The results also indicate that this composite matrix is useful for in vitro tissue engineering.
引用
收藏
页码:545 / 553
页数:9
相关论文
共 25 条
  • [1] Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO
  • [2] 2-M
  • [3] ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294
  • [4] MATRIX ENGINEERING
    BALAZS, EA
    BLAND, PA
    DENLINGER, JL
    GOLDMAN, AI
    LARSEN, NE
    LESHCHINER, EA
    LESHCHINER, A
    MORALES, B
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (01) : 173 - 178
  • [5] BARRY FP, 1998, 44 ANN M ORS NEW ORL
  • [6] MICROSPHERES OF HYALURONIC-ACID ESTERS - FABRICATION METHODS AND INVITRO HYDROCORTISONE RELEASE
    BENEDETTI, LM
    TOPP, EM
    STELLA, VJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 1990, 13 (01) : 33 - 41
  • [7] ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
  • [8] Quantitative assessment of the tissue response to films of hyaluronan derivatives
    Campoccia, D
    Hunt, JA
    Doherty, PJ
    Zhong, SP
    ORegan, M
    Benedetti, L
    Williams, DF
    [J]. BIOMATERIALS, 1996, 17 (10) : 963 - 975
  • [9] In vivo osteogenesis assay: a rapid method for quantitative analysis
    Dennis, JE
    Konstantakos, EK
    Arm, D
    Caplan, AI
    [J]. BIOMATERIALS, 1998, 19 (15) : 1323 - 1328
  • [10] Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold
    Fujisato, T
    Sajiki, T
    Liu, Q
    Ikada, Y
    [J]. BIOMATERIALS, 1996, 17 (02) : 155 - 162